# MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

> **NCT02102646** · PHASE4 · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 31 (actual)

## Conditions studied

- Prostate Cancer
- Metabolic Syndrome
- Hypogonadism
- Fatty Liver

## Interventions

- **DRUG:** Triptorelin
- **PROCEDURE:** Orchiectomy

## Key facts

- **NCT ID:** NCT02102646
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2015-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02102646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02102646, "MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02102646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*